Frazier Healthcare Partners, a private equity firm focused exclusively on the healthcare industry, is pleased to announce that Randy Hyun has joined the firm’s Growth Buyout team as an Executive in Residence. Mr. Hyun will focus on investment opportunities in pharmacy services.

Mr. Hyun brings over two decades of leadership experience across pharmacy services, supply chain, and managed care. He most recently served as President of Evernorth Health System Services, where he was responsible for leading a portfolio of technology-enabled services supporting health systems, providers, and patients, including drug distribution, 340B solutions, specialty pharmacy, and infusion services. Before his tenure at Evernorth, Randy was Chief Executive Officer of CarepathRx, a leading provider of specialty pharmacy, infusion, and telepharmacy solutions to health systems. In this role, he oversaw strategy, growth, and operations across a platform designed to transform hospital pharmacy operations into a driver of clinical and financial performance.

Prior to CarepathRx, Mr. Hyun served as Chief Executive Officer of Aetna Medicaid, where he led a national managed care organization spanning 16 states and approximately $14 billion in revenue. He also led Aetna Pharmacy Management, overseeing the company’s specialty pharmacy, PBM, and mail-order businesses.

Earlier in his career, Mr. Hyun spent 18 years at McKesson, holding a range of senior leadership roles across strategy, business development, and provider solutions, including leading businesses focused on specialty pharmaceuticals and healthcare technology.

Mr. Hyun’s experience sits squarely at the intersection of payors, providers, and pharmacy services, bringing a differentiated perspective on the evolving role of pharmacy across a range of care settings.

“Randy is a highly accomplished healthcare executive with deep expertise across the pharmacy ecosystem,” said Philip Zaorski, General Partner at Frazier. “His leadership experience, combined with his track record of building and scaling leading pharmacy platforms, makes him an exceptional partner as we continue to invest in the sector.”

About Frazier Healthcare Partners:

Founded in 1991, Frazier Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. Since its inception, Frazier has raised over $11 billion of capital for private funds and co-investment opportunities and has invested in more than 200 companies over 34 years. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies. Frazier is headquartered in Seattle, WA, with an office in New York City, and invests broadly across the U.S., Canada, and Europe. For more information about Frazier, visit www.frazierhealthcare.com/home.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260408816680/en/